Saki Manabe

Progression-Free Survival, Response Rate, and Disease Control Rate as Predictors of Overall Survival in Phase III Randomized Controlled Trials Evaluating the First-Line Chemotherapy for Advanced, Locally Advanced, and Recurrent Non–Small Cell Lung Carcinoma

Kentaro Nakashima, Nobuyuki Horita, Kenjiro Nagai et al. · Journal of Thoracic Oncology · 2016 · 25 citations · Full text

Medicine, Oncology, Pharmacology +14

<scp>MicroRNA</scp>‐200b is a potential biomarker of the expression of <scp>PD‐L1</scp> in patients with lung cancer

Seigo Katakura, Nobuaki Kobayashi, Hisashi Hashimoto et al. · Thoracic Cancer · 2020 · 20 citations · Full text

Medicine, Immunology, Oncology +16

Analysis of targeted somatic mutations in pleomorphic carcinoma of the lung using <scp>next‐generation</scp> sequencing technique

Saki Manabe, Rika Kasajima, Shuji Murakami et al. · Thoracic Cancer · 2020 · 19 citations · Full text

Medicine, Molecular Biology, Oncology +17

Nivolumab-induced Vogt-Koyanagi-Harada-like Syndrome and Adrenocortical Insufficiency with Long-term Survival in a Patient with Non-small-cell Lung Cancer

Ryota Ushio, Masaki Yamamoto, Atsushi Miyasaka et al. · Internal Medicine · 2021 · 14 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +16

Long-term mepolizumab treatment reduces relapse rates in super-responders with eosinophilic granulomatosis with polyangiitis

Nami Masumoto, Chiyako Oshikata, Ryo Nakadegawa et al. · Allergy Asthma and Clinical Immunology · 2023 · 11 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17